» Authors » Maximilian Scheer

Maximilian Scheer

Explore the profile of Maximilian Scheer including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 24
Citations 57
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Scheer M, Schenk G, Taute B, Richter M, Hlavac M, Gempt J, et al.
Neurosurg Pract . 2025 Feb; 5(4):e00109. PMID: 39959548
Background And Objective: Venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and pulmonary embolism (PE), is a common complication in craniotomy patients. The duration of surgery has been identified...
2.
Stadsholt S, Strauss A, Kintzel J, Schob S, Elolf E, Rutenkroger M, et al.
Brain Spine . 2025 Feb; 5:104167. PMID: 39898006
Introduction: Posterior reversible encephalopathy syndrome (PRES) is an acute form of encephalopathy. Main characteristic of this syndrome is the development of subcortical/cortical edema in the occipital lobes. The most common...
3.
Nieberlein L, Martin S, Williams K, Gussew A, Cyriaks S, Scheer M, et al.
Hum Brain Mapp . 2024 Dec; 45(18):e70113. PMID: 39723465
The ability to integrate semantic information into the context of a sentence is essential for human communication. Several studies have shown that the predictability of a final keyword based on...
4.
Zimmer K, Scheer M, Scheller C, Leisz S, Strauss C, Taute B, et al.
Acta Neurochir (Wien) . 2024 Nov; 166(1):480. PMID: 39592521
Background Objective: Venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and pulmonary embolism (PE), is a common complication in craniotomy patients and is associated with increased morbidity and mortality....
5.
Scheer M, Polak M, Fritzsche S, Strauss C, Scheller C, Leisz S
Int J Mol Sci . 2024 Oct; 25(19). PMID: 39408743
The chemotherapeutic agent vincristine is commonly used for a variety of hematologic cancers, as well as solid tumors of the head and neck, bronchial carcinoma, as part of the procarbazine,...
6.
Selke P, Strauss C, Horstkorte R, Scheer M
Int J Mol Sci . 2024 Sep; 25(18). PMID: 39337558
Meningiomas are predominantly benign tumors, but there are also malignant forms that are associated with a poor prognosis. Like almost all tumors, meningiomas metabolize glucose as part of aerobic glycolysis...
7.
Rutenkroger M, Wandke S, Gempt J, Duhrsen L, Scheer M, Strauss C, et al.
J Patient Rep Outcomes . 2024 Aug; 8(1):95. PMID: 39136861
Background: Vestibular schwannomas (VSs) are benign tumors of the vestibulocochlear nerve that often cause significant neurological and functional impairment. Patient-reported outcomes, including quality of life (QoL), are essential for understanding...
8.
Thomas M, Fuhres H, Scheer M, Rampp S, Strauss C, Schonfeld R, et al.
J Pers Med . 2024 Jan; 14(1). PMID: 38248776
Postoperative headaches (POHs) following retrosigmoid microsurgery for vestibular schwannoma (VS) can significantly impact patients' perceived health benefits (PHBs). In this cross-sectional observational study, 101 VS patients were investigated. For the...
9.
Schildhauer P, Selke P, Staege M, Harder A, Scheller C, Strauss C, et al.
Cells . 2023 Dec; 12(23). PMID: 38067186
Glioblastoma (GBM) is a highly aggressive brain tumor that often utilizes aerobic glycolysis for energy production (Warburg effect), resulting in increased methylglyoxal (MGO) production. MGO, a reactive dicarbonyl compound, causes...
10.
Thomas M, Rampp S, Scheer M, Strauss C, Prell J, Schonfeld R, et al.
Brain Sci . 2023 Aug; 13(8). PMID: 37626527
Associations between premorbid psychological factors and postoperative headache (POH) after microsurgical treatment via the retrosigmoid approach for vestibular schwannoma (VS) were investigated in this retrospective single-center study. A total of...